4. Ketogenic Diet Improves Metabolic Markers, Psychiatric Symptoms and Cognition in Psychosis: A Randomized Controlled Trial
Juliette Kyner(San Francisco VA Medical Center), Judith M. Ford(San Francisco VA Medical Center), Daniel H. Mathalon(University of California, San Francisco), Susanna L. Fryer(University of California, San Francisco), Samantha V. Abram(University of California, San Francisco), Michael Jacob, An Vu, Zanib Naeem, Shebani Sethi(Stanford Health Care)
Cited by 0
Related Papers
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
|Molecular Psychiatry|2017|733
Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
|Psychiatry Research|2024|129
Ketogenic diet as a metabolic treatment for mental illness
|Current Opinion in Endocrinology Diabetes and Obesity|2020|82
A randomized, placebo‐controlled crossover trial of phentermine‐topiramate ER in patients with binge‐eating disorder and bulimia nervosa
|International Journal of Eating Disorders|2019|67